Skip to main content
SpringerLink
Log in
Book cover

Angiogenesis in Inflammation: Mechanisms and Clinical Correlates pp 83–98Cite as

Chemokines and cytokines in inflammatory angiogenesis

  • Chapter

Part of the book series: Progress in Inflammation Research ((PIR))

Abstract

The perpetuation of angiogenesis is involved in certain chronic inflammatory conditions such as rheumatoid arthritis (RA). Thus, RA, a prototype of chronic inflammatory disorders, as well as other inflammatory diseases with accelerated neovascularisation may be considered as “angiogenic diseases”. Angiogenesis plays an important role in the pathogenesis of the disease and therapeutic control of angiogenesis may be beneficial for the outcome of inflammation (reviewed in [1–6]).

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Koch AE (1998) Angiogenesis: Implications for rheumatoid arthritis. Arthritis Rheum 41: 951–962

    Article  PubMed  CAS  Google Scholar 

  2. Szekanecz Z, Koch AE (2004) Vascular endothelium and immune responses: Implications for inflammation and angiogenesis. Rheum Dis Clin North Am 30: 97–114

    Article  PubMed  Google Scholar 

  3. Szekanecz Z, Koch AE (2001) Chemokines and angiogenesis. Curr Opin Rheumatol 13: 202–208

    Article  PubMed  CAS  Google Scholar 

  4. Auerbach W, Auerbach R (1994) Angiogenesis inhibition: A review. Pharmacol Ther 63: 265–311

    Article  PubMed  CAS  Google Scholar 

  5. Szekanecz Z, Gaspar L, Koch AE (2005) Angiogenesis in rheumatoid arthritis. Front Biosci 10: 1739–1753

    Article  PubMed  CAS  Google Scholar 

  6. Rudolph EH, Woods JM (2005) Chemokine expression and regulation of angiogenesis in rheumatoid arthritis. Curr Pharm Des 11: 613–631

    Article  PubMed  CAS  Google Scholar 

  7. Imhof BA, Aurrand-Lions M (2004) Adhesion mechanisms regulating the migration of monocytes. Nat Rev Immunol 4: 432–444

    Article  PubMed  CAS  Google Scholar 

  8. Szekanecz Z, Strieter RM, Koch AE (1998) Cytokines in rheumatoid arthritis: Potential targets for pharmacological intervention. Drugs Aging 12: 377–390

    Article  PubMed  CAS  Google Scholar 

  9. Koch AE, Polverini PJ, Leibovich SJ (1986) Stimulation of neovascularization by human rheumatoid synovial tissue macrophages. Arthritis Rheum 29: 471–479

    Article  PubMed  CAS  Google Scholar 

  10. Walsh DA (1999) Angiogenesis and arthritis. Rheumatology (Oxford) 38: 103–112

    Article  CAS  Google Scholar 

  11. Paleolog EM, Fava RA (1998) Angiogenesis in rheumatoid arthritis: Implications for future therapeutic strategies. Springer Semin Immunopathol 20: 73–94

    Article  PubMed  CAS  Google Scholar 

  12. Szekanecz Z, Kim J, Koch AE (2002) Chemokines and chemokine receptors in rheumatoid arthritis. Semin Immunol 399: 1–7

    Google Scholar 

  13. Taub DD (1996) C-C chemokines — An overview. In: AE Koch, RM Strieter (eds): Chemokines in Disease. RG Landes Company, Austin, 27–54

    Google Scholar 

  14. Walz A, Kunkel SL, Strieter RM (1996) C-X-C chemokines — An overview. In: AE Koch, RM Strieter (eds): Chemokines in Disease, RG Landes Company, Austin, 1–25

    Google Scholar 

  15. Zlotnik A, Yoshie O (2000) Chemokines: A new classification system and their role in immunity. Immunity 12: 121–127

    Article  PubMed  CAS  Google Scholar 

  16. Moser B, Loetscher P (2001) Lymphocyte traffic control by chemokines. Nat Immunol 2: 123–128

    Article  PubMed  CAS  Google Scholar 

  17. Kunkel EJ, Butcher EC (2002) Chemokines and the tissue-specific migration of lymphocytes. Immunity 16: 1–4

    Article  PubMed  CAS  Google Scholar 

  18. Buckley CD, Amft N, Bradfield PF, Pilling D, Ross E, Arenzana-Seisdedos F, Amara A, Curnow SJ, Lord RM, Scheel-Toellner D, Salmon M (2000) Persistent induction of the chemokine receptor CXCR4 by TGF-beta 1 on synovial T cells contributes to their accumulation within the rheumatoid synovium. J Immunol 165: 3423–3429

    PubMed  CAS  Google Scholar 

  19. Nanki T, Hayashida K, El-Gabalawy HS, Suson S, Shi K, Girschick HJ, Yavuz S, Lipsky PE (2000) Stromal cell-derived factor-1-CXC chemokine receptor 4 interactions play a central role in CD4+ T-cell accumulation in rheumatoid arthritis synovium. J Immunol 165: 6590–6598

    PubMed  CAS  Google Scholar 

  20. Strieter RM, Polverini PJ, Kunkel SL, Arenberg DA, Burdick MD, Kasper J, Dzuiba J, Van Damme J, Walz A, Marriott D et al. (1995) The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J Biol Chem 270: 27348–27357

    Article  PubMed  CAS  Google Scholar 

  21. Salcedo R, Ponce ML, Young HA, Wasserman K, Ward JM, Kleinman HK, Oppenheim JJ, Murphy WJ (2000) Human endothelial cells express CCR2 and respond to MCP-1: Direct role of MCP-1 in angiogenesis and tumor progression. Blood 96: 34–40

    PubMed  CAS  Google Scholar 

  22. Stamatovic SM, Keep RF, Mostarica-Stojkovic M, Andjelkovic AV (2006) CCL2 regulates angiogenesis via activation of Ets-1 transcription factor. J Immunol 177: 2651–2661

    PubMed  CAS  Google Scholar 

  23. Bazan JF, Bacon KB, Hardiman G, Wang W, Soo K, Rossi D, Greaves DR, Zlotnik A, Schall TJ (1997) A new class of membrane bound chemokine with a X3C motif. Nature 385: 640–644

    Article  PubMed  CAS  Google Scholar 

  24. Ruth JH, Volin MV, Haines III GK, Koch AE (2001) Fractalkine, a novel chemokine in rheumatoid arthritis and rat adjuvant-induced arthritis. Arthritis Rheum 44: 1568–1581

    Article  PubMed  CAS  Google Scholar 

  25. Volin MV, Woods JM, Amin MA, Connors MA, Harlow LA, Koch AE (2001) Fractalkine: A novel angiogenic chemokine in rheumatoid arthritis. Am J Pathol 159: 1521–1526

    PubMed  CAS  Google Scholar 

  26. Castor CW, Andrews PC, Swartz RD, Bignall MC, Aaron BP (1993) The origin, variety, distribution, and biologic fate of connective tissue activating peptide-III isoforms: Characteristics in patients with rheumatic, renal, and arterial disease. Arthritis Rheum 36: 1142–1153

    Article  PubMed  CAS  Google Scholar 

  27. Caunt M, Hu L, Tang T, Brooks PC, Ibrahim S, Karpatkin S (2006). Growth-regulated oncogene is pivotal in thrombin-induced angiogenesis. Cancer Res 66: 4125–4132

    Article  PubMed  CAS  Google Scholar 

  28. Wang D, Wang H, Brown J, Daikoku T, Ning W, Shi Q, Richmond A, Strieter R, Dey SK, DuBois RN (2006) CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer. J Exp Med 203: 941–951

    Article  PubMed  CAS  Google Scholar 

  29. Boulday G, Haskova Z, Reinders ME, Pal S, Broiscoe DM (2006) Vascular endothelial growth factor-induced signaling pathways in endothelial cells that mediate overexpression of the chemokine IFN-gamma-inducible protein of 10 kDa in vitro and in vivo. J Immunol 176: 3098–3107

    PubMed  CAS  Google Scholar 

  30. Bodnar RJ, Yates CC, Wells A (2006) IP-10 blocks vascular endothelial growth factor-induced endothelial cell motility and tube formation via inhibition of calpain. Circ Res 98: 617–625

    Article  PubMed  CAS  Google Scholar 

  31. Pablos JL, Santiago B, Galindo M, Torres C, Brehmer M, Blanco FJ, Garcia-Lazaro FJ (2003) Synoviocyte-derived CXCL12 is displayed on endothelium and induces angiogenesis in rheumatoid arthritis. J Immunol 170: 2147–2152

    PubMed  CAS  Google Scholar 

  32. Salcedo R, Wasserman K, Young HA, Grimm MC, Howard OM, Anver MR, Kleinman HK, Murphy WJ, Oppenheim JJ (1999) Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: In vivo neovascularization induced by stromal-derived factor-1 alpha. Am J Pathol 154: 1125–1135

    PubMed  CAS  Google Scholar 

  33. Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, William M, Oz MC, Hicklin DJ, Witte L, Moore MA, Rafii S (2000) Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 95: 952–958

    PubMed  CAS  Google Scholar 

  34. Jin DK, Shido K, Kopp HG, Petit I, Shmelkov SV, Young LM, Hooper AT, Raffii S (2006) Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes. Nat Med 12: 557–567

    Article  PubMed  CAS  Google Scholar 

  35. Burns JM, Summers BC, Wang Y, Melikian A, Miao Z, Kuo CJ, Wei K, Wright K, Howard MC, Schall TJ (2006) A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion and tumor development. J Exp Med 203: 2201–2213

    Article  PubMed  CAS  Google Scholar 

  36. Calatozzolo C, Maderna E, Pollo B, Gelati M, Marras C, Silvani A, Croci D, Boiardi A, Salmaggi A (2006) Prognostic value of CXCL12 expression in 40 low-grade oligodendrogliomas and oligoastrocytomas. Cancer Biol Ther 5: 827–832

    PubMed  CAS  Google Scholar 

  37. Fujii T, Yonemitsu Y, Onimaru M, Tanii M, Inoue M, Hasegawa M, Kuwano H, Sueishi K (2006) Nonendothelial mesenchymal cell-derived MCP-1 is required for FGF-2 mediated therapeutic neovascularization. Arterioscler Thromb Vasc Biol 26: 2483–2489

    Article  PubMed  CAS  Google Scholar 

  38. Vicari AP, Ait-Yahia S, Chemin K, Mueller A, Zlotnik A, Caux C (2000) Antitumor effects of the mouse chemokine 6 Ckine/SLC through angiostatic and immunological mechanisms. J Immunol 165: 1992–2000

    PubMed  CAS  Google Scholar 

  39. Son KN, Hwang J, Kwon BS, Kim J (2006) Human CC chemokine CCL23 enhances expression of matrix metalloproteinase-2 and invasion of vascular endothelial cells. Biochem Biophys Res Commun 340: 498–504

    Article  PubMed  CAS  Google Scholar 

  40. Lesnik P, Haskell CA, Charo IF (2003) Decreased atherosclerosis in CX3CR1 −/− mice reveals a role for fractalkine in atherogenesis. J Clin Invest 111: 333–340

    PubMed  CAS  Google Scholar 

  41. McDermott DH, Fong AM, Yang Q (2003) Chemokine receptor mutant CX3CR1-M280 has impaired adhesive function and correlates with protection from cardiovascular disease in humans. J Clin Invest 111: 1241–1250

    PubMed  CAS  Google Scholar 

  42. Borzi RM, Mazzetti I, Cattini L (2000) Human chondrocytes express functional chemokine receptors and release matrix-degrading enzymes in response to C-X-C and C-C chemokines. Arthritis Rheum 43: 1734–1741

    Article  PubMed  CAS  Google Scholar 

  43. Patterson AM, Siddall H, Chamberlain G (2002) Expression of the Duffy antigen/receptor for chemokines (DARC) by the inflamed synovial endothelium. J Pathol 197: 108–116

    Article  PubMed  CAS  Google Scholar 

  44. Wang J, Ou ZL, Hou YF, Luo JM, Shen ZZ, Ding J, Shao ZM (2006) Enhanced expression of Duffy antigen receptor for chemokines by breast cancer cells attenuates growth and metastasis potential. Oncogene 25: 7201–7211

    Article  PubMed  CAS  Google Scholar 

  45. Fava RA, Olsen NJ, Spencer-Green G, Yeo KT, Yeo TK, Berse B, Jackman RW, Senger DR, Dvorak HF, Brown LF (1994) Vascular permeability factor/endothelial growth factor (VPF/VEGF): Accumulation and expression in human synovial fluids and rheumatoid synovial tissue. J Exp Med 180: 341–346

    Article  PubMed  CAS  Google Scholar 

  46. Koch AE, Harlow LA, Haines GK, Amento EP, Unemori EN, Wong WL, Pope RM, Ferrara N (1994) Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis. J Immunol 152: 4149–4156

    PubMed  CAS  Google Scholar 

  47. Esser S, Wolburg K, Wolburg H, Breier G, Kurzchalia T, Risau W (1998) Vascular endothelial growth factor induces endothelial fenestrations in vitro. J Cell Biol 140: 947–959

    Article  PubMed  CAS  Google Scholar 

  48. Qu Z, Huang XN, Ahmadi P, Andresevic J, Planck SR, Hart CE, Rosenbaum JT (1995) Expression of basic fibroblast growth factor in synovial tissue from patients with rheumatoid arthritis and degenerative joint disease. Lab Invest 73: 339–346

    PubMed  CAS  Google Scholar 

  49. Goddard DH, Grossman SL, Williams WV, Weiner DB, Gross JL, Eidsvoog K (1992) Regulation of synovial cell growth: Coexpression of transforming growth factor β and basic fibroblast growth factor by cultured synovial cells. Arthritis Rheum 35: 1296–1303

    PubMed  CAS  Google Scholar 

  50. Szekanecz Z, Haines GK, Harlow LA, Shah MR, Fong TW, Fu R, Lin SJ-W, Rayan G, Koch AE (1995) Increased synovial expression of transforming growth factor (TGF)-β receptor endoglin and TGF-β1 in rheumatoid arthritis: Possible interactions in the pathogenesis of the disease. Clin Immunol Immunopathol 76: 187–194

    Article  PubMed  CAS  Google Scholar 

  51. Park CC, Morel JC, Amin MA, Connors MA, Harlow LA, Koch AE (2001) Evidence of IL-18 as a novel angiogenic mediator. J Immunol 167: 1644–1653

    PubMed  CAS  Google Scholar 

  52. Voronov E, Shouval DS, Krelin Y, Cagnano E, Benharroch D, Iwakuchi Y, Dinarello CA, Apte RN (2003) IL-1 is required for tumor invasiveness and angiogenesis. Proc Natl Acad Sci USA 100: 2645–2650

    Article  PubMed  CAS  Google Scholar 

  53. Angiolillo AL, Kanegane H, Sgadari C, Reaman GH, Tosato G (1997) Interleukin-15 promotes angiogenesis in vivo. Biochem Biophys Res Commun 233: 231–237

    Article  PubMed  CAS  Google Scholar 

  54. Numasaki M, Watanabe M, Suzuki T, Takahashi H, Nakamura A, Goto J, Lotze MT, Sasaki H (2005) IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR2-dependent angiogenesis. J Immunol 175: 6177–6189

    PubMed  CAS  Google Scholar 

  55. Leibovich SJ, Polverini PJ, Shepard HM, Wiseman DM, Shively V, Nuseir N (1987) Macrophage-induced angiogenesis is mediated by tumour necrosis factor-α. Nature 329: 630–632

    Article  PubMed  CAS  Google Scholar 

  56. Nakao S, Kuwano T, Ueda S, Kimura YN, Saijo Y, Nukiwa T, Strieter RM, Ishibashi T, Kuwano M, Ono M (2005) Infiltration of COX-2-expressing macrophages is a prerequisite for IL-1 beta-induced neovascularization and tumor growth. J Clin Invest 115: 2979–2991

    Article  PubMed  CAS  Google Scholar 

  57. Wijelath ES, Carlsen B, Cole T, Chen J, Kothari S, Hammond WP (1997) Oncostatin M induces basic fibroblast growth factor expression in endothelial cells and promotes endothelial cell proliferation, migration and spindle morphology. J Cell Sci 110: 871–879

    PubMed  CAS  Google Scholar 

  58. Koch AE, Fong TW, Volpert OV, Halloran MM, Bouck NP (1996) Interleukin-4 is an inhibitor of angiogenesis. Arthritis Rheum 39: S304

    Article  Google Scholar 

  59. Voest EE, Kenyon BM, O—Reilly MS, Truitt G, D’Amato RJ, Folkman J (1995) Inhibition of angiogenesis in vivo by interleukin 12. J Natl Cancer Inst 87: 581–586

    Article  PubMed  CAS  Google Scholar 

  60. Waring PM, Carroll GJ, Kandiah DA, Buirski G, Metcalf D (1993) Increased levels of leukemia inhibitory factor in synovial fluid from patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum 36: 911–915

    Article  PubMed  CAS  Google Scholar 

  61. Loetscher P, Dewald B, Baggiolini M, Seitz M (1994) Monocyte chemoattractant protein 1 and interleukin 8 production by rheumatoid synoviocytes Effects of anti-rheumatic drugs. Cytokine 6: 162–170

    Article  PubMed  CAS  Google Scholar 

  62. Seitz M, Dewald B, Gerber N, Baggiolini M (1991) Enhanced production of neutrophilactivating peptide-1/interleukin-8 in rheumatoid arthritis. J Clin Invest 87: 463–469

    Article  PubMed  CAS  Google Scholar 

  63. Volin MV, Harlow LA, Woods JM, Campbell PL, Amin MA, Tokuhira M, Koch AE (1999) Treatment with sulfasalazine or sulfapyridine, but not 5-aminosalicyclic acid, inhibits basic fibroblast growth factor-induced endothelial cell chemotaxis. Arthritis Rheum 42: 1927–1935

    Article  PubMed  CAS  Google Scholar 

  64. Taylor PC, Peters AM, Paleolog E, Chapman PT, Elliott MJ, McCloskey R, Feldmann M, Maini RN (2000) Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritis. Arthritis Rheum 43: 38–47

    Article  PubMed  CAS  Google Scholar 

  65. Coxon A, Bolon B, Estrada J, Kaufman S, Scully S, Rattan A, Duryen D, Hu YL, Rex K, Pacheco E et al (2002) Inhibition of interleukin-1 but not tumor necrosis factor suppresses neovascularization in rat models of corneal angiogenesis and adjuvant arthritis. Arthritis Rheum 46: 2604–2612

    Article  PubMed  CAS  Google Scholar 

  66. Kingsley G, Panayi G, Lanchbury J (1991) Immunotherapy of rheumatic disease — Practice and prospects. Immunol Today 12: 177–179

    Article  PubMed  CAS  Google Scholar 

  67. Shibuya M (2003) VEGF-receptor inhibitors for anti-angiogenesis. Nippon Yakurigaku Zasshi 122: 498–503

    PubMed  CAS  Google Scholar 

  68. Zhang R, Tian L, Chen LJ, Hou JM, Li G, Li J, Zhang L, Chen XC, Luo F, Jiang Y, Wei YQ (2006) Combination of MIG (CXCL9) chemokine gene therapy with lowdose cisplatin improves therapeutic efficacy against murine carcinoma. Gene Ther 13: 1263–1271

    Article  PubMed  CAS  Google Scholar 

  69. Wente MN, Keane MP, Burdick MD, Friess H, Buchler MW, Ceyhan GO, Reber HA, Strieter RM, Hines OJ (2006) Blockade of the chemokine receptor CXCR2 inhibits pancreatic cancer cell-induced angiogenesis. Cancer Lett 241: 221–227

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Rheumatology, Third Department of Medicine, University of Debrecen Medical and Health Sciences Centre, Debrecen, 4004, Hungary

    Zoltán Szekanecz

  2. Veterans’ Administration, Ann Arbor Healthcare System, Ann Arbor, MI, USA

    Alisa E. Koch

  3. Department of Internal Medicine, Division of Rheumatology, University of Michigan Health System, Ann Arbor, MI, USA

    Alisa E. Koch

Authors
  1. Zoltán Szekanecz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alisa E. Koch
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Centre for Experimental Medicine and Rheumatology William Harvey Research Institute, St. Bartholomew’s Hospital, Charterhouse Square, London, E1M 6BQ, UK

    Michael P. Seed

  2. Academic Rheumatology, University of Nottingham, Clinical Sciences Building City Hospital Hucknall Road, Nottingham, NG5 1PB, UK

    David A. Walsh

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Birkhäuser Verlag Basel/Switzerland

About this chapter

Cite this chapter

Szekanecz, Z., Koch, A.E. (2008). Chemokines and cytokines in inflammatory angiogenesis. In: Seed, M.P., Walsh, D.A. (eds) Angiogenesis in Inflammation: Mechanisms and Clinical Correlates. Progress in Inflammation Research. Birkhäuser Basel. https://doi.org/10.1007/978-3-7643-7650-5_6

Download citation

Publish with us

Policies and ethics

Search

Navigation